Kimberly Magana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kimberly Magana has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Kyle Fitzgerald
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA
5 shared publications - Matt Vassar
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
5 shared publications - Alicia Ito Ford
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications - Garrett Jones
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications - Jay Modi
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications - Shaelyn Ward
Oklahoma State Univ, Off Med Student Res, Ctr Hlth Sci, Tulsa, OK USA
4 shared publications
Latest Publications
- 19 September 2024
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 37 (6) , 970-975
Treatment in persistent genital arousal disorder: a scoping review
Persistent genital arousal disorder (PGAD) is a rare condition characterized by unwanted and distressing symptoms of arousal and dysesthesia. The aim of this scoping review was to map the current state of PGAD management, identify gaps in the literature, and understand patient perspectives. We completed a scoping review following guidelines from the Joanna Briggs Institute and the Preferred Reporting Items for Systematic Reviews and Meta Analyses Scoping Reviews extension. A systematic literature search for articles pertaining to PGAD/genito-pelvic dysesthesia (GPD) was conducted in August 2023 via Medline, Embase, Scopus, and Web of Science. The search returns were deduplicated and the remaining titles and abstracts were screened for inclusion. General publication characteristics and treatment data were extracted from the included publications via a pilot-tested Google form. All screening and extraction were completed in a masked, duplicate fashion. Findings from our scoping review revealed a scarcity of systematic research, limited evidence-based data, and the importance of addressing both physical and psychiatric concerns. Our sample included 46 publications from an initial pool of 636 returns. Case studies were the most common study design. Thirty-three studies examined medication, either alone or as part of a treatment regimen. Selective serotonin reuptake inhibitors were the most used medication, followed by pramipexole and carbamazepine. Seven studies used a surgical or procedural intervention. Treatment with pelvic floor Botox was the most common procedure. Patient perspectives in the included case studies highlighted themes of shame, suicidal ideation, social isolation, decreased sleep, and overall decline in quality of life. The findings from our study emphasize patients’ distressing and psychiatric symptoms, indicating a need to improve treatment regimens, using both evidence-based research outcomes and patient-reported outcomes. Management for PGAD/GPD lacks a standardized framework, indicating a need for further research and the development of clinical practice guidelines to improve patient care.
- 19 September 2024
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 37 (6) , 970-975
Treatment in persistent genital arousal disorder: a scoping review
Persistent genital arousal disorder (PGAD) is a rare condition characterized by unwanted and distressing symptoms of arousal and dysesthesia. The aim of this scoping review was to map the current state of PGAD management, identify gaps in the literature, and understand patient perspectives. We completed a scoping review following guidelines from the Joanna Briggs Institute and the Preferred Reporting Items for Systematic Reviews and Meta Analyses Scoping Reviews extension. A systematic literature search for articles pertaining to PGAD/genito-pelvic dysesthesia (GPD) was conducted in August 2023 via Medline, Embase, Scopus, and Web of Science. The search returns were deduplicated and the remaining titles and abstracts were screened for inclusion. General publication characteristics and treatment data were extracted from the included publications via a pilot-tested Google form. All screening and extraction were completed in a masked, duplicate fashion. Findings from our scoping review revealed a scarcity of systematic research, limited evidence-based data, and the importance of addressing both physical and psychiatric concerns. Our sample included 46 publications from an initial pool of 636 returns. Case studies were the most common study design. Thirty-three studies examined medication, either alone or as part of a treatment regimen. Selective serotonin reuptake inhibitors were the most used medication, followed by pramipexole and carbamazepine. Seven studies used a surgical or procedural intervention. Treatment with pelvic floor Botox was the most common procedure. Patient perspectives in the included case studies highlighted themes of shame, suicidal ideation, social isolation, decreased sleep, and overall decline in quality of life. The findings from our study emphasize patients’ distressing and psychiatric symptoms, indicating a need to improve treatment regimens, using both evidence-based research outcomes and patient-reported outcomes. Management for PGAD/GPD lacks a standardized framework, indicating a need for further research and the development of clinical practice guidelines to improve patient care.
- Open Access
- 15 August 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 41, 101347
Assessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysis
- 15 August 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 41, 101347
Open AccessAssessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysis
- 5 June 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (8) , 2275-2283
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis
- 5 June 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (8) , 2275-2283
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis
- 7 January 2024
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 207, 111085
Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study
- 7 January 2024
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 207, 111085
Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study
- 27 September 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 91, 102081
Assessing uptake of the core outcome set in randomized controlled trials for Parkinson’s disease: A systematic review
- 27 September 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 91, 102081
Assessing uptake of the core outcome set in randomized controlled trials for Parkinson’s disease: A systematic review
- 17 November 2022
- Published by BMJ in Sexually Transmitted Infections
- Vol. 99 (2) , 128-136
Health inequities in human papillomavirus prevention, diagnostics and clinical care in the USA: a scoping review
Background Human papillomavirus (HPV) represents the most common STI in the USA. HPV inequities in prevention, diagnostics and clinical care persist. We define inequities as systematic, avoidable and unfair differences in health outcomes. Objectives The objectives of this scoping review are to chart existing data on HPV-related inequities, identify gaps in existing literature and guide future research to reduce these inequities. Methods We completed a scoping review following guidelines from the Joanna Briggs Institute and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses scoping reviews extension. We performed a literature search on PubMed and Ovid Embase in July 2022 for articles pertaining to HPV and evaluating populations within the USA. We included English language publications from 2018 to 2022 evaluating at least one health inequity outlined by the National Institutes of Health. General publication characteristics and health inequity data were charted in a masked, duplicate fashion using a pilot-tested Google Form. We analysed frequencies of health inequities and summarised main findings from included studies. Results Our final sample included 170 publications. The most common inequities examined were race/ethnicity (140 studies), sex or gender (97 studies), and income (69 studies). Many historically marginalised racial/ethnic groups had lower rates of HPV-related knowledge, vaccination and worse overall outcomes related to HPV. Compared with women, men had lower rates of HPV vaccination and provider recommendation, and higher rates of HPV-infection. Results regarding income were largely conflicting. Conclusion Findings from our review demonstrate clear gaps in HPV-related inequity research. Vaccine completion, provider recommendation and intersectionality should continue to be evaluated to implement targeted interventions.
- 17 November 2022
- Published by BMJ in Sexually Transmitted Infections
- Vol. 99 (2) , 128-136
Health inequities in human papillomavirus prevention, diagnostics and clinical care in the USA: a scoping review
Background Human papillomavirus (HPV) represents the most common STI in the USA. HPV inequities in prevention, diagnostics and clinical care persist. We define inequities as systematic, avoidable and unfair differences in health outcomes. Objectives The objectives of this scoping review are to chart existing data on HPV-related inequities, identify gaps in existing literature and guide future research to reduce these inequities. Methods We completed a scoping review following guidelines from the Joanna Briggs Institute and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses scoping reviews extension. We performed a literature search on PubMed and Ovid Embase in July 2022 for articles pertaining to HPV and evaluating populations within the USA. We included English language publications from 2018 to 2022 evaluating at least one health inequity outlined by the National Institutes of Health. General publication characteristics and health inequity data were charted in a masked, duplicate fashion using a pilot-tested Google Form. We analysed frequencies of health inequities and summarised main findings from included studies. Results Our final sample included 170 publications. The most common inequities examined were race/ethnicity (140 studies), sex or gender (97 studies), and income (69 studies). Many historically marginalised racial/ethnic groups had lower rates of HPV-related knowledge, vaccination and worse overall outcomes related to HPV. Compared with women, men had lower rates of HPV vaccination and provider recommendation, and higher rates of HPV-infection. Results regarding income were largely conflicting. Conclusion Findings from our review demonstrate clear gaps in HPV-related inequity research. Vaccine completion, provider recommendation and intersectionality should continue to be evaluated to implement targeted interventions.